Home LiteratureArticle Details
PMID: 1526645 Published · ppublish English Editorial Review

Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Immunology ·Vol. 76 ·No. 3 ·1992-07-00 ·Pages 349-54

Tärnvik A, Eriksson M, Sandström G, Sjöstedt A

Abstract

暂无摘要

MeSH Terms
Animals Antigens, Bacterial/immunology Bacterial Vaccines/immunology Francisella tularensis/immunology Humans Immunity, Cellular/physiology Lymphokines/immunology Rats T-Lymphocyte Subsets/immunology T-Lymphocytes/immunology Tularemia/immunology,prevention & control
Chemicals
Antigens, Bacterial Bacterial Vaccines Lymphokines
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tärnvik A
Eriksson M
Sandström G
Sjöstedt A
References (86)
86 references, click to expand
  1. Infection-immunity in tularemia: specificity of cellular immunity.
    Infect Immun. 1972 Mar;5(3):311-8 PMID: 4564560
  2. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.
    J Exp Med. 1969 Jun 1;129(6):1367-84 PMID: 4977283
  3. In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis.
    J Bacteriol. 1966 Sep;92(3):645-51 PMID: 5922539
  4. Failure of killed Listeria monocytogenes vaccine to produce protective immunity.
    Nature. 1982 May 20;297(5863):233-4 PMID: 6176874
  5. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants.
    J Exp Med. 1984 Feb 1;159(2):365-77 PMID: 6198430
  6. Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions.
    Infect Immun. 1984 Jul;45(1):101-6 PMID: 6203835
  7. A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes.
    Infect Immun. 1984 Feb;43(2):730-4 PMID: 6319290
  8. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.
    Eur J Immunol. 1984 Oct;14(10):964-7 PMID: 6436036
  9. A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia.
    J Infect Dis. 1984 Dec;150(6):912-5 PMID: 6501932
  10. The role of cell-mediated immunity in bacterial infections.
    Rev Infect Dis. 1981 Nov-Dec;3(6):1221-50 PMID: 6805064
  11. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes.
    Infect Immun. 1983 Feb;39(2):715-20 PMID: 6832815
  12. Cell-mediated immunity against Francisella tularensis after natural infection.
    Scand J Infect Dis. 1980;12(4):281-7 PMID: 7006062
  13. Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.
    Infect Immun. 1982 Jun;36(3):983-9 PMID: 7095859
  14. Immunity against Francisella tularensis in northern Finland.
    Scand J Infect Dis. 1982;14(3):195-9 PMID: 7146829
  15. Tularemia vaccine study. I. Intracutaneous challenge.
    Arch Intern Med. 1961 May;107:689-701 PMID: 13746668
  16. Immunity against tularemia: passive protection of mice by transfer of immune tissues.
    J Exp Med. 1962 Feb 1;115:411-20 PMID: 13860583
  17. Soviet viable Pasteurella tularensis vaccines. A review of selected articles.
    Bacteriol Rev. 1962 Sep;26:354-73 PMID: 13985026
  18. Hemagglutination by tularemia antisera: further observations on agglutination of polysaccharide-treated erythrocytes and its inhibition by polysaccharide.
    J Immunol. 1952 Jan;68(1):65-71 PMID: 14908085
  19. Observations on the agglutination of polysaccharide-treated erythrocytes by tularemia antisera.
    J Exp Med. 1950 Jun 1;91(6):561-6 PMID: 15422083
  20. Prevention of pneumococcal pneumonia by vaccination.
    Trans Assoc Am Physicians. 1976;89:184-94 PMID: 14433
  21. Tularaemia in the rat. I. The cellular basis on host resistance to infection.
    Immunology. 1975 May;28(5):855-69 PMID: 236983
  22. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.
    Infect Immun. 1978 Jun;20(3):698-704 PMID: 307538
  23. Time of lymphocyte response after onset of tularemia and after tularemia vaccination.
    J Clin Microbiol. 1979 Dec;10(6):854-60 PMID: 521485
  24. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.
    J Infect Dis. 1977 Jan;135(1):55-60 PMID: 833449
  25. Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.
    Infect Immun. 1975 Nov;12(5):951-7 PMID: 1193733
  26. Sequence analysis of peptides bound to MHC class II molecules.
    Nature. 1991 Oct 17;353(6345):622-7 PMID: 1656276
  27. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
    Infect Immun. 1991 Jun;59(6):1948-53 PMID: 1674737
  28. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals.
    J Clin Microbiol. 1990 Jan;28(1):43-8 PMID: 1688874
  29. Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas.
    Infect Immun. 1990 Jun;58(6):1538-44 PMID: 1692805
  30. Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis.
    J Immunol. 1990 Jul 1;145(1):311-7 PMID: 1694206
  31. Diversity of Francisella tularensis antigens recognized by human T lymphocytes.
    Infect Immun. 1990 Aug;58(8):2664-8 PMID: 1695207
  32. Use of prior vaccinations for the development of new vaccines.
    Science. 1990 Jul 27;249(4967):423-5 PMID: 1696030
  33. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Nature. 1991 May 23;351(6324):290-6 PMID: 1709722
  34. Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course.
    Infect Immun. 1991 Jul;59(7):2265-73 PMID: 1711013
  35. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes.
    Nature. 1991 Oct 31;353(6347):852-5 PMID: 1719425
  36. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.
    J Clin Invest. 1991 Jul;88(1):346-50 PMID: 1829097
  37. Selection of a human T helper type 1-like T cell subset by mycobacteria.
    J Exp Med. 1991 Sep 1;174(3):583-92 PMID: 1831489
  38. The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein.
    Infect Immun. 1991 Sep;59(9):3163-8 PMID: 1879938
  39. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.
    J Immunol. 1990 Jun 15;144(12):4651-6 PMID: 1972164
  40. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia.
    Res Microbiol. 1990 Sep-Oct;141(7-8):887-91 PMID: 2101478
  41. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Nature. 1990 Nov 15;348(6298):248-51 PMID: 2234092
  42. T-cell antigenic sites tend to be amphipathic structures.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048-52 PMID: 2413457
  43. T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity.
    Immunology. 1986 Oct;59(2):167-71 PMID: 2429917
  44. Strong conformational propensities enhance T cell antigenicity.
    J Immunol. 1987 Jan 1;138(1):204-12 PMID: 2431054
  45. A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using human T-lymphocyte clones.
    Immunology. 1987 Jan;60(1):1-5 PMID: 2434413
  46. Antiviral cytotoxic T lymphocyte induction and vaccination.
    Rev Infect Dis. 1988 Jan-Feb;10(1):16-33 PMID: 2451265
  47. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells.
    J Immunol. 1988 Oct 15;141(8):2749-54 PMID: 2459228
  48. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
    Nature. 1988 Dec 22-29;336(6201):778-80 PMID: 2462673
  49. Identification of mycobacterial antigens recognized by T lymphocytes.
    Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S443-7 PMID: 2469121
  50. Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.
    J Clin Invest. 1989 Jun;83(6):1868-75 PMID: 2470787
  51. Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production.
    Infect Immun. 1989 Sep;57(9):2906-8 PMID: 2474506
  52. Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis.
    Microb Pathog. 1989 Jun;6(6):403-14 PMID: 2475738
  53. Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting.
    Infect Immun. 1989 Oct;57(10):2971-6 PMID: 2476395
  54. The mapping of epitopes of the 18-kDa protein of Mycobacterium leprae recognized by murine T cells in a proliferation assay.
    J Immunol. 1989 Sep 15;143(6):2006-12 PMID: 2476491
  55. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
    Eur J Immunol. 1989 Nov;19(11):2075-9 PMID: 2480902
  56. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.
    J Immunol. 1989 May 15;142(10):3581-4 PMID: 2497175
  57. Molecular study of the T cell repertoire in family contacts and patients with leprosy.
    J Immunol. 1989 May 15;142(10):3599-604 PMID: 2497176
  58. Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.
    J Immunol. 1989 Oct 15;143(8):2656-62 PMID: 2507635
  59. The requirement for gamma interferon in resistance of mice to experimental tularemia.
    Microb Pathog. 1989 Dec;7(6):421-8 PMID: 2516219
  60. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
    Annu Rev Immunol. 1989;7:145-73 PMID: 2523712
  61. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
    Nature. 1989 Jun 1;339(6223):383-5 PMID: 2524668
  62. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals.
    Microb Pathog. 1989 Dec;7(6):411-9 PMID: 2622330
  63. Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones.
    J Immunol. 1989 Apr 15;142(8):2873-8 PMID: 2649562
  64. Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens.
    Infect Immun. 1989 Aug;57(8):2475-80 PMID: 2663725
  65. Nature of protective immunity to Francisella tularensis.
    Rev Infect Dis. 1989 May-Jun;11(3):440-51 PMID: 2665002
  66. Immunity to tuberculosis from the perspective of pathogenesis.
    Infect Immun. 1989 Dec;57(12):3671-6 PMID: 2680977
  67. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
    J Immunol. 1989 Aug 15;143(4):1268-73 PMID: 2787362
  68. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
    J Exp Med. 1989 Mar 1;169(3):691-705 PMID: 2926324
  69. Structural model of HLA-DR1 restricted T cell antigen recognition.
    Cell. 1988 Feb 26;52(4):515-23 PMID: 2963699
  70. Immunization against tuberculosis: what kind of vaccine?
    Infect Immun. 1988 Nov;56(11):2769-73 PMID: 3049373
  71. Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy.
    Infect Immun. 1986 Mar;51(3):879-83 PMID: 3081446
  72. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.
    J Immunol. 1986 Oct 15;137(8):2662-9 PMID: 3093580
  73. The antigenic and mitogenic response of murine T and B lymphocytes to soluble proteins of Listeria monocytogenes.
    J Immunol. 1987 Apr 15;138(8):2671-8 PMID: 3104472
  74. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles.
    J Immunol Methods. 1987 Apr 2;98(1):5-10 PMID: 3104476
  75. Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.
    J Clin Microbiol. 1987 Jun;25(6):1074-8 PMID: 3110207
  76. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
    Scand J Immunol. 1988 May;27(5):515-25 PMID: 3131867
  77. Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus by using protein immunoblotting.
    Infect Immun. 1988 Oct;56(10):2581-6 PMID: 3138178
  78. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.
    Infect Immun. 1988 Dec;56(12):3310-2 PMID: 3141288
  79. The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice.
    Microb Pathog. 1986 Apr;1(2):221-4 PMID: 3150025
  80. CD8+ T lymphocytes in intracellular microbial infections.
    Immunol Today. 1988 Jun;9(6):168-74 PMID: 3151440
  81. H-2 restriction in acquired cell-mediated immunity to infection with Francisella tularensis LVS.
    Infect Immun. 1988 Feb;56(2):452-6 PMID: 3257461
  82. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.
    Infect Immun. 1988 May;56(5):1194-202 PMID: 3356465
  83. Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.
    J Clin Microbiol. 1987 Apr;25(4):641-4 PMID: 3494744
  84. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
    Microb Pathog. 1987 Jan;2(1):3-14 PMID: 3507552
  85. Interleukin 2 production in whole blood culture: a rapid test of immunity to Francisella tularensis.
    J Clin Microbiol. 1985 Aug;22(2):318-9 PMID: 3875626
  86. Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine.
    J Clin Microbiol. 1985 Oct;22(4):527-30 PMID: 3878364
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
0019-2805
Published
1992-07-00
Pages
349-54
Language
English
Region
England
NLM ID
0374672
PMCID
PMC1421695
Subset
IM
External Links
PubMed source PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2